High Incidence of Renal Stones in Severely Disabled Children with Epilepsy Treated with Topiramate

Abstract

Purpose This study was aimed to assess the accurate incidence of renal stones in severely disabled children treated with topiramate (TPM).

Method We reviewed the medical records of severely disabled children with epilepsy under 15 years old who underwent radiological examinations to investigate urinary stones. The study enrolled 26 patients who were divided into two groups. One group had been treated with TPM for at least 1 year and the other had not been treated with TPM, zonisamide, acetazolamide, or other diuretic drugs. We collected parameters from the medical records and compared the groups.

Results All participants were evaluated radiologically, with computed tomography (CT) in two patients, ultrasonography in 22 patients, and both in two. No patient had any morphological abnormality of the kidneys and history of urinary tract infection. There were no significant differences in sex, age, body weight, or feeding manner between the groups, while the incidence of renal stones or calcifications was significantly higher in the TPM-treated group (60 vs. 0%; p = 0.00241).

Conclusion There is a high incidence of renal stone formation in severely disabled children treated with TPM.

Keywords

severely disabled children with epilepsy - antiepileptic drug - topiramate - renal stone - nonambulatory children

• References

• 1 Maryanoff BE, Costanzo MJ, Nortey SO. , et al. Structure-activity studies on anticonvulsant sugar sulfamates related to topiramate. Enhanced potency with cyclic sulfate derivatives. J Med Chem 1998; 41 (08) 1315-1343
• 2 Rho JM, Sankar R. The pharmacologic basis of antiepileptic drug action. Epilepsia 1999; 40 (11) 1471-1483
• 3 Vega D, Maalouf NM, Sakhaee K. Increased propensity for calcium phosphate kidney stones with topiramate use. Expert Opin Drug Saf 2007; 6 (05) 547-557
• 4 Mahmoud AAH, Rizk T, El-Bakri NK, Riaz M, Dannawi S, Al Tannir M. Incidence of kidney stones with topiramate treatment in pediatric patients. Epilepsia 2011; 52 (10) 1890-1893
• 5 Coppola G, Capovilla G, Montagnini A. , et al. Topiramate as add-on drug in severe myoclonic epilepsy in infancy: an Italian multicenter open trial. Epilepsy Res 2002; 49 (01) 45-48
• 6 Sas DJ, Hulsey TC, Shatat IF, Orak JK. Increasing incidence of kidney stones in children evaluated in the emergency department. J Pediatr 2010; 157 (01) 132-137
• 7 Dwyer ME, Krambeck AE, Bergstralh EJ, Milliner DS, Lieske JC, Rule AD. Temporal trends in incidence of kidney stones among children: a 25-year population based study. J Urol 2012; 188 (01) 247-252
• 8 Tasian GE, Ross ME, Song L. , et al. Annual incidence of nephrolithiasis among children and adults in South Carolina from 1997 to 2012. Clin J Am Soc Nephrol 2016; 11 (03) 488-496
• 9 Yoshida O, Terai A, Ohkawa T, Okada Y. National trend of the incidence of urolithiasis in Japan from 1965 to 1995. Kidney Int 1999; 56 (05) 1899-1904
• 10 Goyal M, Grossberg RI, O'Riordan MA, Davis ID. Urolithiasis with topiramate in nonambulatory children and young adults. Pediatr Neurol 2009; 40 (04) 289-294
• 11 Spivacow FR, Negri AL, del Valle EE, Calviño I, Fradinger E, Zanchetta JR. Metabolic risk factors in children with kidney stone disease. Pediatr Nephrol 2008; 23 (07) 1129-1133
• 12 Alpay H, Ozen A, Gokce I, Biyikli N. Clinical and metabolic features of urolithiasis and microlithiasis in children. Pediatr Nephrol 2009; 24 (11) 2203-2209
• 13 Welch BJ, Graybeal D, Moe OW, Maalouf NM, Sakhaee K. Biochemical and stone-risk profiles with topiramate treatment. Am J Kidney Dis 2006; 48 (04) 555-563
• 14 Corbin Bush N, Twombley K, Ahn J. , et al. Prevalence and spot urine risk factors for renal stones in children taking topiramate. J Pediatr Urol 2013; 9 (6, Pt A) 884-889
• 15 Müller CE, Bianchetti M, Kaiser G. Immobilization, a risk factor for urinary tract stones in children. A case report. Eur J Pediatr Surg 1994; 4 (04) 201-204
• 16 Korkes F, Segal AB, Heilberg IP, Cattini H, Kessler C, Santili C. Immobilization and hypercalciuria in children. Pediatr Nephrol 2006; 21 (08) 1157-1160
• 17 Tasdemir HA, Buyukavci M, Akcay F, Polat P, Yildiran A, Karakelleoglu C. Bone mineral density in children with cerebral palsy. Pediatr Int 2001; 43 (02) 157-160
• 18 Smith PJ, Basravi S, Schlomer BJ. , et al. Comparative analysis of nephrolithiasis in otherwise healthy versus medically complex gastrostomy fed children. J Pediatr Urol 2011; 7 (03) 244-247
• 19 Passerotti C, Chow JS, Silva A. , et al. Ultrasound versus computerized tomography for evaluating urolithiasis. J Urol 2009; ; 182 (4, Suppl): 1829-1834
• 20 Morrison JC, Kawal T, Van Batavia JP, Srinivasan AK. Use of ultrasound in pediatric renal stone diagnosis and surgery. Curr Urol Rep 2017; 18 (03) 22